Overview Open Label Extension Study of INBRX-101 in Adults With AATD Emphysema Status: Not yet recruiting Trial end date: 2027-12-01 Target enrollment: Participant gender: Summary Phase 2 open label extension study to evaluate INBRX-101 in adults with AATD emphysema Phase: Phase 2 Details Lead Sponsor: Inhibrx, Inc.